Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma

Fig. 4

Correlation of genomic alterations with response to CR-CHOP. a Epigenetic gene mutations by whole genome sequencing and targeted sequencing in 36 patients. The number of patients with mutations was listed on the right. b Forest plot of univariate analysis on PFS and OS in patients with or without epigenetic gene mutations. PFS = Progression-free survival. OS = Overall survival 

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us